Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil · Delayed Price · Currency is BRL 97.00
-2.78 (-2.79%)
Last updated: Jan 14, 2026, 4:20 PM GMT-3
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 254.82 billion as of January 16, 2026. Its market cap has increased by 34.30% in one year.
Market Cap
254.82B
Enterprise Value
255.08B
Revenue
17.11B
Ranking
n/a
PE Ratio
1,097.53
Stock Price
97.00
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 361.82M to 254.82B, an increase of 70,327.92%. That is a compound annual growth rate of 35.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 254.82B | -11.94% |
| Dec 31, 2025 | 289.36B | 54.15% |
| Dec 31, 2024 | 187.71B | 61.05% |
| Dec 29, 2023 | 116.56B | -24.59% |
| Dec 30, 2022 | 154.57B | 36.78% |
| Dec 31, 2021 | 113.01B | 44.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.76B |
| Raia Drogasil | 41.34B |
| Hypera | 14.79B |
| Fleury | 8.25B |
| Odontoprev | 6.03B |
| Diagnósticos da América | 5.24B |
| Empreendimentos Pague Menos | 4.26B |
| Oncoclínicas do Brasil Serviços Médicos | 2.93B |